Pharmacologically active substances are classified on the basis of opinions on maximum residue limits (MRLs) issued by the European Medicines Agency (EMA). Those opinions consist of a scientific risk assessment and risk management considerations.
Recital 1, Regulation (EU) 2017/880
In forcesince 23 May 2017